Copyright
©2007 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 7, 2007; 13(41): 5465-5470
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5465
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5465
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study
Toru Ishikawa, Michitaka Imai, Hiroteru Kamimura, Atsunori Tsuchiya, Tadayuki Togashi, Kouji Watanabe, Kei-ichi Seki, Hironobu Ohta, Toshiaki Yoshida, Tomoteru Kamimura, Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Niigata 950-1104, Japan
Author contributions: All authors contributed equally to the work.
Correspondence to: Toru Ishikawa, MD, Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Teraji 280-7, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp
Telephone: +81-25-2336161 Fax: +81-25-2338880
Received: June 23, 2007
Revised: August 6, 2007
Accepted: September 4, 2007
Published online: November 7, 2007
Revised: August 6, 2007
Accepted: September 4, 2007
Published online: November 7, 2007
Core Tip